While some of the effects on co-chaperone function could be perceived to be beneficial to the prognosis of AD, such as reducing the Hsp90-dependent activity of FKBP51, other effects on CHIP and PP5 activity might appear to be counterproductive. This evidence concerns the gene FKBP4 and Alzheimer disease.